申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20150284382A1
公开(公告)日:2015-10-08
Compounds having the following formula (I) or a stereoisomer or a pharmaceutically-acceptable salt thereof, wherein R
2
is a monocyclic heteroaryl group, and R
1
, R
3
, R
4
, R
5
and R
6
are as defined herein, are useful as kinase modulators, including IRAK-4 inhibition.
具有以下式(I)或其立体异构体或药学上可接受的盐的化合物,其中R2是单环杂环基团,而R1、R3、R4、R5和R6如所定义的,可用作激酶调节剂,包括IRAK-4抑制剂。